
Investigational ADC is Well Tolerated with Partial-Dose-depended Response in NSCLC
Medical Health News,
Square of Spain - National museum of Barcelona with fountain at summer day, Spain, retro toned Results of a Phase I clinical…
Square of Spain - National museum of Barcelona with fountain at summer day, Spain, retro toned Results of a Phase I clinical…
Updated results presented for investigational TROP2 targeting ADC DS-1062 in unselected patients with unresectable advanced…
TOKYO, MUNICH, and BASKING RIDGE, N.J., Sept. 10, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi…
TOKYO, MUNICH, and BASKING RIDGE, N.J., Sept. 10, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi…
- Updated results presented for investigational TROP2 targeting ADC DS-1062 in unselected patients with unresectable advanced…
- Updated results presented for investigational TROP2 targeting ADC DS-1062 in unselected patients with unresectable advanced…
TOKYO, MUNICH, and BASKING RIDGE, N.J., Sept. 10, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi…